Aberdeen Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Aberdeen Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$30.1M	Buy	172,235 +1,813	+1%	+$305K	0.1%	199
2017 Q1	$26.2M	Buy	170,422 +6,820	+4%	+$1.04M	0.09%	203
2016 Q4	$23.1M	Sell	163,602 -39,696	-20%	-$5.85M	0.09%	210
2016 Q3	$32.3M	Sell	203,298 -2,689	-1%	-$414K	0.12%	140
2016 Q2	$30.4M	Sell	205,987 -2,500	-1%	-$369K	0.11%	133
2016 Q1	$29.5M	Sell	208,487 -9,474	-4%	-$1.27M	0.11%	132
2015 Q4	$27M	Buy	217,961 +18,558	+9%	+$2.48M	0.09%	142
2015 Q3	$24.4M	Sell	199,403 -1,742	-0.9%	-$227K	0.08%	140
2015 Q2	$26.1M	Sell	201,145 -6,478	-3%	-$845K	0.08%	147
2015 Q1	$27.9M	Sell	207,623 -74,262	-26%	-$9.57M	0.08%	145
2014 Q4	$35.3M	Sell	281,885 -212,768	-43%	-$25.9M	0.09%	126
2014 Q3	$60.2M	Sell	494,653 -46,967	-9%	-$5.71M	0.13%	90
2014 Q2	$63.9M	Buy	541,620 +500,765	+1,226%	+$58.9M	0.13%	92
2014 Q1	$4.91M	Buy	40,855 +2,900	+8%	+$345K	0.01%	187
2013 Q4	$4.19M	Hold	37,955	–	–	0.01%	206
2013 Q3	$3.5M	Sell	37,955 -4,060	-10%	-$367K	0.01%	218
2013 Q2	$3.56M	Buy	+42,015	New	+$3.5M	0.01%	210

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Aberdeen Asset Management's TMO Position: Q2 2017 in Review

Aberdeen Asset Management increased its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2017, buying an estimated $305K and bringing the position to 172,235 shares worth $30.1M. The position accounts for 0.1% of the portfolio, ranked #199.

Aberdeen Asset Management first reported a position in TMO in Q2 2013 and has held it in 17 quarters since. The position peaked at $63.9M in Q2 2014. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

Aberdeen Asset Management held 172,235 shares of Thermo Fisher Scientific worth $30.1M as of Q2 2017.
Aberdeen Asset Management bought 1,813 Thermo Fisher Scientific shares in Q2 2017, an estimated $305K.
Thermo Fisher Scientific made up 0.1% of Aberdeen Asset Management's portfolio in Q2 2017, its #199 holding.
Aberdeen Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Thermo Fisher Scientific position peaked at $63.9M in Q2 2014.
1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.